Lance Armstrong, Susan Komen, and Me - Lani Horn PhD, January 22nd, 2013
A WELL-MEANING PERSON ASKS: “So, have you found life to be more meaningful now that you are a survivor?”
I’ve been asked variations of this question ever since I finished treatment for breast cancer, and my answer has always been some version of the word NO, sometimes with colorful verbiage added to emphasize my . . . → Read More: Lance Armstrong, Susan Komen, and Me
Facing Cancer, A Stark Choice - Posted By BCC Admin, January 21st, 2013
“Facing Cancer, A Stark Choice.” By Tara Parker-Pope, The New York Times
In the 1970s, women’s health advocates were highly suspicious of mastectomies. They argued that surgeons — in those days, pretty much an all-male club — were far too quick to remove a breast after a diagnosis of cancer, with disfiguring results. But today, . . . → Read More: Facing Cancer, A Stark Choice
Living With Stage IV Breast Cancer - Posted By BCC Admin, January 15th, 2013
“Living With Stage IV Breast Cancer.” By Algerina Perna, The Darkroom, a photography and video blog of The Baltimore Sun
In September 2012, I photographed a group of women diagnosed with terminal stage IV breast cancer: Kay Campbell, Gretchen Carlquist, Dian “CJ” Corneliussen-James, Cecilia “Cece” Curry , and Sally Ring. As I photographed these women, . . . → Read More: Living With Stage IV Breast Cancer
Bias in reporting of end points of efficacy and toxicity - Posted By BCC Admin, January 11th, 2013
“Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer.” By F.E. Vera-Badillo, R. Shapiro, A. Ocana, E. Amir and I.F. Tannock, Annals of oncology (PDF)
Of the 164 studies included in a literature review of Phase III randomized, clinical trials (RCTs) from 1995 to 2011, . . . → Read More: Bias in reporting of end points of efficacy and toxicity
Patients with life expectancy of less than 10 years derive little benefit from screening - Posted By BCC Admin, January 9th, 2013
“Time lag to benefit after screening for breast and colorectal cancer: meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark. By S.J. Lee and colleagues, British Medical Journal.
Clinical practice guidelines recommend targeting breast and colorectal cancer screening to healthy older patients who have a substantial life expectancy. Cancer screening is . . . → Read More: Patients with life expectancy of less than 10 years derive little benefit from screening
Remembering BCC Member Marie-Laurence Waldelöf - Gayle Sulik PhD, January 8th, 2013
Marie-Laurence Waldelöf died of breast cancer on December 25, 2012.
Fluent in french, swedish, and british english, Marie-Laurence Waldelöf of Paris, France specialized in copywriting and communications. After her breast cancer diagnosis in 2009, Marie-Laurence began exploring the cultures and contexts of breast cancer. Triumphant survivorship did not represent her reality, as a patient, . . . → Read More: Remembering BCC Member Marie-Laurence Waldelöf
NCI Cancer Bulletin Suspends Publication - Posted By BCC Admin, January 8th, 2013
“NCI Cancer Bulletin Suspends Publication, National Cancer Institute.
As of January 8, 2013, the NCI Cancer Bulletin has suspended publication. A searchable archive of more than 5,000 news and feature stories published since 2004 will remain on NCI’s website. Featured clinical trials and summaries highlighting recent results from cancer clinical trials will continue to be . . . → Read More: NCI Cancer Bulletin Suspends Publication
Breast Screening Costs High for Seniors - Posted By BCC Admin, January 8th, 2013
“Breast Screening Costs High for Seniors.” By Nancy Walsh, MedPage today
Costs associated with screening for breast cancer among older women remain high, with considerable geographic variation as well as some potentially undesirable implications for diagnosis, a retrospective study found. The annual cost to Medicare for breast cancer screening among women 66 and older was . . . → Read More: Breast Screening Costs High for Seniors
Billions Paid Out for Surgical Errors - Posted By BCC Admin, December 26th, 2012
“Billions Paid Out for Surgical Errors.” By Cole Petrochko, MedPage Today
Surgical “never events” — such as leaving a sponge in a patient — cost healthcare professionals a minimum of $1.3 billion in malpractice payouts from 1990 to 2010, researchers found. In an analysis of such surgical mishaps, a mean of $133,055 per event was . . . → Read More: Billions Paid Out for Surgical Errors
What’s the matter with those sexy breast cancer campaigns? - Gayle Sulik PhD, December 13th, 2012
In a post I wrote for Psychology Today (Nov. 21, 2012) I asked, “Do Sexy Breast Cancer Campaigns Demean Women?” The answer was yes. I identified six sexually objectifying techniques commonly used in breast cancer awareness campaigns to get attention, raise money, and lure people to the Cause.
Use women’s bodies as literal objects (canvases, . . . → Read More: What’s the matter with those sexy breast cancer campaigns?
|
|